F. Castagna

558 total citations
18 papers, 413 citations indexed

About

F. Castagna is a scholar working on Toxicology, Spectroscopy and Molecular Biology. According to data from OpenAlex, F. Castagna has authored 18 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Toxicology, 7 papers in Spectroscopy and 5 papers in Molecular Biology. Recurrent topics in F. Castagna's work include Forensic Toxicology and Drug Analysis (10 papers), Analytical Chemistry and Chromatography (5 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). F. Castagna is often cited by papers focused on Forensic Toxicology and Drug Analysis (10 papers), Analytical Chemistry and Chromatography (5 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). F. Castagna collaborates with scholars based in Italy and United States. F. Castagna's co-authors include L. Tedeschi, Gilles Frison, Santo Davide Ferrara, G. L. Gessa, Pietro Palatini, Luigi Gallimberti, Raffaele Giorgetti, Donata Favretto, S. D. Ferrara and Giulia Stocchero and has published in prestigious journals such as British Journal of Clinical Pharmacology, Rapid Communications in Mass Spectrometry and Journal of Pharmaceutical and Biomedical Analysis.

In The Last Decade

F. Castagna

16 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Castagna Italy 9 269 114 104 89 62 18 413
Robert E. Joseph United States 8 351 1.3× 92 0.8× 132 1.3× 87 1.0× 95 1.5× 8 579
Joseph Magluilo United States 14 233 0.9× 105 0.9× 71 0.7× 83 0.9× 116 1.9× 17 671
Albert A. Elian United States 13 314 1.2× 141 1.2× 73 0.7× 82 0.9× 65 1.0× 19 455
Daniel S. Isenschmid United States 12 311 1.2× 75 0.7× 138 1.3× 60 0.7× 118 1.9× 19 467
Anders Just Pedersen Denmark 10 237 0.9× 101 0.9× 76 0.7× 80 0.9× 83 1.3× 13 390
Alan D. Brailsford United Kingdom 13 165 0.6× 131 1.1× 122 1.2× 81 0.9× 22 0.4× 15 433
Cornelius Heß Germany 13 257 1.0× 131 1.1× 71 0.7× 109 1.2× 111 1.8× 26 536
Stefano Gentili Italy 11 232 0.9× 59 0.5× 49 0.5× 127 1.4× 70 1.1× 13 414
P. R. Stout United States 12 201 0.7× 60 0.5× 46 0.4× 66 0.7× 96 1.5× 20 361
Siegfried Zörntlein Germany 12 214 0.8× 61 0.5× 77 0.7× 58 0.7× 138 2.2× 16 362

Countries citing papers authored by F. Castagna

Since Specialization
Citations

This map shows the geographic impact of F. Castagna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Castagna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Castagna more than expected).

Fields of papers citing papers by F. Castagna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Castagna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Castagna. The network helps show where F. Castagna may publish in the future.

Co-authorship network of co-authors of F. Castagna

This figure shows the co-authorship network connecting the top 25 collaborators of F. Castagna. A scholar is included among the top collaborators of F. Castagna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Castagna. F. Castagna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Favretto, Donata, et al.. (2013). When color fails: Illicit blue tablets containing anabolic androgen steroids. Journal of Pharmaceutical and Biomedical Analysis. 83. 260–264. 8 indexed citations
2.
Favretto, Donata, Giulia Stocchero, Susanna Vogliardi, et al.. (2010). Neonatal Hair Analysis by Liquid Chromatography-High-Resolution Mass Spectrometry to Reveal Gestational Exposure to Venlafaxine. Therapeutic Drug Monitoring. 32(1). 30–39. 19 indexed citations
3.
Ferrara, Santo Davide, Alessandro Nalesso, F. Castagna, et al.. (2007). Simultaneous determination of atracurium and its metabolite laudanosine in post‐mortem fluids by liquid chromatography/multiple‐stage mass spectrometry on an ion trap. Rapid Communications in Mass Spectrometry. 21(18). 2944–2950.
4.
Tedeschi, L., et al.. (2004). Amphetamines and 3,4-methylendioxymetamphetamine (MDMA): evaluation of KIMS (kinetic interaction of microparticles in solution) assay at two cut-off levels. Clinical Chemistry and Laboratory Medicine (CCLM). 42(5). 543–8. 1 indexed citations
5.
Giorgetti, Raffaele, et al.. (2000). USE OF BREATH TEST AS EVIDENCE. COMPARISON BETWEEN BRACS AND BACS IN A DRIVING POPULATION. 2000.
6.
Ferrara, Santo Davide, Gilles Frison, Raffaele Giorgetti, et al.. (2000). Alcol, droga, farmaci e sicurezza stradale. Research Padua Archive (University of Padua). 36. 29–40. 2 indexed citations
7.
Ferrara, S. D., Gilles Frison, Raffaele Giorgetti, et al.. (2000). [Alcohol, drugs, pharmacologic agents, and street safety].. PubMed. 36(1). 29–40. 9 indexed citations
8.
Ferrara, Santo Davide, et al.. (1999). Proficiency testing for psychoactive substances in Italy. International Journal of Legal Medicine. 113(1). 50–54. 4 indexed citations
9.
Giorgetti, Raffaele, et al.. (1995). LOW BLOOD ALCOHOL CONCENTRATIONS AND PSYCHOMOTOR PERFORMANCE IN TOLERATING AND NON-TOLERATING SUBJECTS. 2. 640–646. 1 indexed citations
10.
Ferrara, Santo Davide, et al.. (1994). Drugs-of-Abuse Testing in Urine: Statistical Approach and Experimental Comparison of Immunochemical and Chromatographic Techniques. Journal of Analytical Toxicology. 18(5). 278–291. 74 indexed citations
11.
Ferrara, Santo Davide, L. Tedeschi, Gilles Frison, et al.. (1993). Therapeutic gamma-hydroxybutyric acid monitoring in plasma and urine by gas chromatography—mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 11(6). 483–487. 75 indexed citations
12.
Tedeschi, L., Gilles Frison, F. Castagna, Raffaele Giorgetti, & Santo Davide Ferrara. (1993). Simultaneous identification of amphetamine and its derivatives in urine using HPLC-UV. International Journal of Legal Medicine. 105(5). 265–269. 22 indexed citations
13.
Ferrara, Santo Davide, L. Tedeschi, Gilles Frison, & F. Castagna. (1992). Solid-Phase Extraction and HPLC—UV Confirmation of Drugs of Abuse in Urine. Journal of Analytical Toxicology. 16(4). 217–222. 37 indexed citations
14.
Tedeschi, L., Gilles Frison, F. Castagna, et al.. (1992). Pharmacokinetics of gamma‐hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses.. British Journal of Clinical Pharmacology. 34(3). 231–235. 132 indexed citations
15.
Castagna, F., et al.. (1982). Direct and Indirect Homogeneous Enzyme Immunoassay of Benzodiazepines in Biological Fluids and Tissues. Journal of Analytical Toxicology. 6(1). 22–25. 16 indexed citations
16.
Ferrara, S. D. & F. Castagna. (1982). [Drugs of abuse and street accidents in Italy].. PubMed. 18(4). 769–74. 1 indexed citations
17.
Ferrara, S. D., L. Tedeschi, F. Castagna, & M. Marigo. (1978). Comparison of GLC-EMIT analysis for the assay of methadone and its major metabolite in urine. Forensic Science. 11(1). 181–188. 5 indexed citations
18.
Ferrara, Santo Davide, L. Tedeschi, F. Castagna, & M. Marigo. (1978). Comparison of GLC-EMIT analysis for the assay of methadone and its major metabolite in urine. Forensic Science. 11(3). 181–188. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026